Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Strategic faculty recruitment and development in a research-intensive school of nursing: A case for a mission-driven, human-centered approach.

Journal of professional nursing : official journal of the American Association of Colleges of Nursing·2026

Same author

The Interaction of Pain Catastrophizing and Chronic Pain Acceptance in Sickle Cell.

Pain management nursing : official journal of the American Society of Pain Management Nurses·2025

Same author

Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey.

Rheumatology international·2022

Same author

Photosensitivity Is Associated with Chronic Pain following Traumatic Brain Injury.

Journal of neurotrauma·2022

Same author

Fibromyalgia: A clinical update.

The Nurse practitioner·2022

Same author

Chronic Pain Clinical and Prescriptive Practices in the Cannabis Era.

Pain management nursing : official journal of the American Society of Pain Management Nurses·2022

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Novel pharmacotherapy for fibromyalgia.

Patrick B Wood¹, Andrew J Holman, Kim D Jones

¹Louisiana State University Health Sciences Center--Shreveport, Department of Family Medicine, Shreveport, LA 71130, USA. pwood@lsuhsc.edu

Expert Opinion on Investigational Drugs

|May 16, 2007

Summary

Fibromyalgia, a disorder causing widespread pain and fatigue, lacks a clear model hindering treatment. New research offers hope for effective therapies by exploring its pathophysiology and potential subgroups.

More Related Videos

Efficacy of Fu's Subcutaneous Needling on Sciatic Nerve Pain: Behavioral and Electrophysiological Changes in a Chronic Constriction Injury Rat Model

Efficacy of Fu's Subcutaneous Needling on Sciatic Nerve Pain: Behavioral and Electrophysiological Changes in a Chronic Constriction Injury Rat Model

Published on: June 30, 2023

Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Published on: March 24, 2023

Related Experiment Videos

Last Updated: Jul 14, 2026

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Efficacy of Fu's Subcutaneous Needling on Sciatic Nerve Pain: Behavioral and Electrophysiological Changes in a Chronic Constriction Injury Rat Model

Efficacy of Fu's Subcutaneous Needling on Sciatic Nerve Pain: Behavioral and Electrophysiological Changes in a Chronic Constriction Injury Rat Model

Published on: June 30, 2023

Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Published on: March 24, 2023

Area of Science:

Rheumatology and Pain Medicine
Neuroscience
Pharmacology

Background:

Fibromyalgia is a complex disorder characterized by chronic widespread pain, fatigue, and sleep disturbances.
The absence of a well-established pathophysiological model impedes the development of effective treatments for fibromyalgia.
Understanding the underlying mechanisms is crucial for advancing therapeutic strategies.

Purpose of the Study:

To review potential models explaining the pathophysiology of fibromyalgia, particularly chronic widespread pain.
To evaluate the mechanistic basis of medications under consideration for fibromyalgia treatment.
To highlight the importance of identifying biologic subgroups for personalized treatment approaches.

Main Methods:

Literature review of existing models for fibromyalgia pathophysiology.
Mechanistic evaluation of pharmacological agents relevant to fibromyalgia treatment.
Analysis of basic research insights for therapeutic potential.

Main Results:

Several potential models were reviewed, offering insights into the primary symptom of chronic widespread pain.
Mechanistic evaluations suggest potential therapeutic avenues for novel and existing medications.
Identification of biologic subgroups within the fibromyalgia spectrum is proposed as key for adequate treatment.

Conclusions:

Advances in basic research provide a basis for optimism regarding effective fibromyalgia relief.
Future treatment strategies may involve targeted therapies based on identified biologic subgroups.
A better understanding of fibromyalgia pathophysiology is essential for improving patient outcomes.